Chieron Active Ingredients Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is LEVETIRACETAM, with a corresponding US DMF Number 35316.
Remarkably, this DMF maintains an Active status since its submission on October 27, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 05, 2024, and payment made on July 15, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II